Key facts
- It has raised $1.5M; the latest was IPO in Jan 2026.
- Notable investors include Puhua Capital, Hengqin Financial Investment, Hangshang Capital, Xingtuo Capital.
- Status: In IPO Registration.
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Doctor Licorice
- ·The full record, as it builds
Funding rounds
No funding rounds for Doctor Licorice are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Doctor Licorice
Manufacturer of plant-based health products aims to promote natural wellness through modern biotechnology. The company's offerings feature herbal extracts, functional foods, and nutritional supplements, supported by advanced R&D in natural active ingredient extraction, quality control, and formulation, helping customers benefit from safe, effective, and science-based plant-derived solutions, enabling healthier lifestyles and sustainable wellness.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2015
- Website
- gancao.com/
- Ownership
- In IPO Registration
Doctor Licorice doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Doctor Licorice shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Doctor Licorice in its N-PORT filings yet. We sweep new filings monthly.